180 related articles for article (PubMed ID: 38610885)
21. Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers?
Çetinarslan T; Türel Ermertcan A; Özyurt B; Gündüz K
Dermatol Ther; 2021 Mar; 34(2):e14835. PubMed ID: 33527638
[TBL] [Abstract][Full Text] [Related]
22. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.
Wang P; Guo X; Zhou Y; Li Z; Yu S; Sun Y; Hua Y
Front Endocrinol (Lausanne); 2022; 13():944991. PubMed ID: 36157453
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome.
Chen H; Xiong C; Shao X; Ning J; Gao P; Xiao H; Chen Y; Zou Z; Hong G; Li X; Shao M; Sheng J; Yang X; You X; Zou H
Diabetes Metab Syndr Obes; 2019; 12():2117-2123. PubMed ID: 31686883
[TBL] [Abstract][Full Text] [Related]
24. Association of Three Novel Inflammatory Markers: Lymphocyte to HDL-C Ratio, High-Sensitivity C-Reactive Protein to HDL-C Ratio and High-Sensitivity C-Reactive Protein to Lymphocyte Ratio With Metabolic Syndrome.
Kolahi Ahari R; Akbari N; Babaeepoor N; Fallahi Z; Saffar Soflaei S; Ferns G; Ebrahimi M; Moohebati M; Esmaily H; Ghayour-Mobarhan M
Endocrinol Diabetes Metab; 2024 May; 7(3):e00479. PubMed ID: 38590230
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil to High-density Lipoprotein ratio (NHR) as a potential predictor of disease severity and survival time in Creutzfeldt-Jakob disease.
Kong Y; Chen Z; Zhang J; Wu L
BMC Neurol; 2023 Jan; 23(1):34. PubMed ID: 36690949
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma.
Shi K; Hou J; Zhang Q; Bi Y; Zeng X; Wang X
Front Nutr; 2023; 10():1127913. PubMed ID: 37215223
[TBL] [Abstract][Full Text] [Related]
27. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study.
Aslan Çin NN; Yardımcı H; Koç N; Uçaktürk SA; Akçil Ok M
J Pediatr Endocrinol Metab; 2020 May; 33(6):777-784. PubMed ID: 32447329
[TBL] [Abstract][Full Text] [Related]
28. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
29. Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography.
Okan T; Topaloglu C
Cardiovasc J Afr; 2024 Jan; 34():1-6. PubMed ID: 38276874
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome.
Uslu AU; Sekin Y; Tarhan G; Canakcı N; Gunduz M; Karagulle M
Clin Appl Thromb Hemost; 2018 Jul; 24(5):828-833. PubMed ID: 29212375
[TBL] [Abstract][Full Text] [Related]
31. High Tg/HDL-Cholesterol Ratio Highlights a Higher Risk of Metabolic Syndrome in Children and Adolescents with Severe Obesity.
Radetti G; Grugni G; Lupi F; Fanolla A; Caroli D; Bondesan A; Sartorio A
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956105
[TBL] [Abstract][Full Text] [Related]
32. A Single-Point Insulin Sensitivity Estimator (SPISE) of 5.4 is a good predictor of both metabolic syndrome and insulin resistance in adolescents with obesity.
Correa-Burrows P; Matamoros M; de Toro V; Zepeda D; Arriaza M; Burrows R
Front Endocrinol (Lausanne); 2023; 14():1078949. PubMed ID: 36843603
[TBL] [Abstract][Full Text] [Related]
33. The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients.
Yu Q; Weng W; Luo H; Yan J; Zhao X
Infect Drug Resist; 2022; 15():4529-4539. PubMed ID: 35992755
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease.
Wu Z; Cui H; Li W; Zhang Y; Liu L; Liu Z; Zhang W; Zheng T; Yang J
Front Cardiovasc Med; 2022; 9():918359. PubMed ID: 35966520
[TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus.
Gong S; Gan S; Zhang Y; Zhou H; Zhou Q
Front Endocrinol (Lausanne); 2023; 14():1248614. PubMed ID: 37854188
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the ability of HOMA-IR, VAI, and TyG indexes to predict metabolic syndrome in children with obesity: a cross-sectional study.
Dundar C; Terzi O; Arslan HN
BMC Pediatr; 2023 Feb; 23(1):74. PubMed ID: 36765298
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiological characteristics of metabolic syndrome among Kazakh children aged from 6 to 13 in Xinjiang, China].
Li M; Zhang T; Xu PR
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Apr; 34(4):336-41. PubMed ID: 23937836
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Novel Biomarkers of Insulin Resistance With Homeostasis Model Assessment of Insulin Resistance, Its Correlation to Metabolic Syndrome in South Indian Population and Proposition of Population Specific Cutoffs for These Indices.
Jog KS; Eagappan S; Santharam RK; Subbiah S
Cureus; 2023 Jan; 15(1):e33653. PubMed ID: 36788883
[TBL] [Abstract][Full Text] [Related]
39. Cardiometabolic risk factors among children who are affected by overweight, obesity and severe obesity.
Nur Zati Iwani AK; Jalaludin MY; Roslan FA; Mansor F; Md Zain F; Hong JYH; Zin RMWM; Yahya A; Ishak Z; Selamat R; Mokhtar AH
Front Public Health; 2023; 11():1097675. PubMed ID: 37181686
[TBL] [Abstract][Full Text] [Related]
40. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS).
Vizzuso S; Del Torto A; Dilillo D; Calcaterra V; Di Profio E; Leone A; Gilardini L; Bertoli S; Battezzati A; Zuccotti GV; Verduci E
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
